Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 6 November 2012
Vol. 5, Issue 249, p. ra79
[DOI: 10.1126/scisignal.2003257]
RESEARCH ARTICLES
Key Roles for the Lipid Signaling Enzyme Phospholipase D1 in the Tumor Microenvironment During Tumor Angiogenesis and Metastasis
Qin Chen1*,
Tsunaki Hongu2*,
Takanobu Sato2,
Yi Zhang1,
Wahida Ali1,3,
Julie-Ann Cavallo1,3,
Adrianus van der Velden4,
Huasong Tian5,
Gilbert Di Paolo5,
Bernhard Nieswandt6,
Yasunori Kanaho2, and
Michael A. Frohman1,3
1 Department of Pharmacological Sciences and Center for Developmental Genetics, Stony Brook University, Stony Brook, NY 11794–5140, USA. 2 Department of Physiological Chemistry, Graduate School of Comprehensive Human Sciences and Institute of Basic Medical Sciences, University of Tsukuba, 1-1-1 Ten-nohdai, Tsukuba 305-8575, Japan. 3 Graduate Program in Molecular and Cellular Pharmacology, Stony Brook University, Stony Brook, NY 11794–8651, USA. 4 Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794–5120, USA. 5 Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA. 6 University Hospital and Rudolf Virchow Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg, Germany.
* These authors contributed equally to this work.
Present address: Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Abstract:
Angiogenesis inhibitors, which target tumor cells, confer only short-term benefits on tumor growth. We report that ablation of the lipid signaling enzyme phospholipase D1 (PLD1) in the tumor environment compromised the neovascularization and growth of tumors. PLD1 deficiency suppressed the activation of Akt and mitogen-activated protein kinase signaling pathways by vascular endothelial growth factor in vascular endothelial cells, resulting in decreased integrin-dependent cell adhesion to, and migration on, extracellular matrices, as well as reduced tumor angiogenesis in a xenograft model. In addition, mice lacking PLD1 incurred fewer lung metastases than did wild-type mice. Bone marrow transplantation and binding studies identified a platelet-derived mechanism involving decreased tumor cell–platelet interactions, in part because of impaired activation of αIIbβ3 integrin in platelets, which decreased the seeding of tumor cells into the lung parenchyma. Treatment with a small-molecule inhibitor of PLD1 phenocopied PLD1 deficiency, efficiently suppressing both tumor growth and metastasis in mice. These findings reveal that PLD1 in the tumor environment promotes tumor growth and metastasis and, taken together with previous reports on the roles of PLD in tumor cell–intrinsic adaptations to stress, suggest the potential use of PLD inhibitors as cancer therapeutics.
To whom correspondence should be addressed. E-mail: michael{at}pharm.stonybrook.edu
Citation: Q. Chen, T. Hongu, T. Sato, Y. Zhang, W. Ali, J.-A. Cavallo, A. van der Velden, H. Tian, G. Di Paolo, B. Nieswandt, Y. Kanaho, M. A. Frohman, Key Roles for the Lipid Signaling Enzyme Phospholipase D1 in the Tumor Microenvironment During Tumor Angiogenesis and Metastasis. Sci. Signal.5, ra79 (2012).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
RESEARCH ARTICLES
Guanglei Zhuang, Kebing Yu, Zhaoshi Jiang, Alicia Chung, Jenny Yao, Connie Ha, Karen Toy, Robert Soriano, Benjamin Haley, Elizabeth Blackwood, Deepak Sampath, Carlos Bais, Jennie R. Lill, and Napoleone Ferrara (16 April 2013) Sci. Signal.6 (271), ra25.
[DOI: 10.1126/scisignal.2003572] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
EDITORIAL GUIDES
Nancy R. Gough (26 March 2013) Sci. Signal.6 (268), eg3.
[DOI: 10.1126/scisignal.2004149] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
John F. Foley (13 November 2012) Sci. Signal.5 (250), ec291.
[DOI: 10.1126/scisignal.2003770] |Abstract »
PODCASTS
Michael A. Frohman and Annalisa M. VanHook (6 November 2012) Sci. Signal.5 (249), pc25.
[DOI: 10.1126/scisignal.2003723] |Abstract »|Full Text »|Podcast »
PERSPECTIVES
Brian M. Wiczer and George Thomas (27 March 2012) Sci. Signal.5 (217), pe13.
[DOI: 10.1126/scisignal.2003019] |Abstract »|Full Text »|PDF »
RESEARCH ARTICLES
Margitta Elvers, David Stegner, Ina Hagedorn, Christoph Kleinschnitz, Attila Braun, Marijke E. J. Kuijpers, Michael Boesl, Qin Chen, Johan W. M. Heemskerk, Guido Stoll, Michael A. Frohman, and Bernhard Nieswandt (5 January 2010) Sci. Signal.3 (103), ra1.
[DOI: 10.1126/scisignal.2000551] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Phosphatidic Acid-dependent Recruitment and Function of the Rac Activator DOCK1 during Dorsal Ruffle Formation.
F. Sanematsu, A. Nishikimi, M. Watanabe, T. Hongu, Y. Tanaka, Y. Kanaho, J.-F. Cote, and Y. Fukui (2013)
J. Biol. Chem.
288, 8092-8100
|Abstract »|Full Text »|PDF »
Science Signaling Podcast: 6 November 2012.
M. A. Frohman and A. M. VanHook (2012)
Science Signaling
5, pc25
|Abstract »|Full Text »